Literature DB >> 911222

The family history method using diagnostic criteria. Reliability and validity.

N C Andreasen, J Endicott, R L Spitzer, G Winokur.   

Abstract

Data concerning familial history of psychiatric disorders are often used to assist in diagnosis, to examine the role of genetic or nongenetic familial factors in etiology, or to develop new methods of classification. Information concerning familial prevalence may be collected by two different methods: the family history method (obtaining information from the patinet or a relative concerning all family members), and the family study method (interviewing directly as many relatives as possible concerning their own present or past symptomatology). This study compares these two methods. In general, the family study method is preferred since information is likely to be more accurate. The family history method leads to significant underreporting, but this can be minimized through the use of diagnostic criteria. This study reports on an instrument that has been developed for collecting information concerning family history and that provides criteria for 12 diagnoses--the Family History-Research Diagnostic Criteria. Using diagnostic criteria leads to greater sensitivity, but underreporting remains a major problem of the family history method.

Entities:  

Mesh:

Year:  1977        PMID: 911222     DOI: 10.1001/archpsyc.1977.01770220111013

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  376 in total

1.  Recreational gamblers with and without parental addiction.

Authors:  Liana Renée Nelson Schreiber; Brian Lawrence Odlaug; Jon Edgar Grant
Journal:  Psychiatry Res       Date:  2012-03-07       Impact factor: 3.222

2.  Working memory and decision-making biases in young adults with a family history of alcoholism: studies from the Oklahoma family health patterns project.

Authors:  William R Lovallo; Eldad Yechiam; Kristen H Sorocco; Andrea S Vincent; Frank L Collins
Journal:  Alcohol Clin Exp Res       Date:  2006-05       Impact factor: 3.455

3.  A new method for rapidly and simultaneously decreasing serotonin and catecholamine synthesis in humans.

Authors:  Marco Leyton; Valerie Kwai Pun; Chawki Benkelfat; Simon N Young
Journal:  J Psychiatry Neurosci       Date:  2003-11       Impact factor: 6.186

4.  The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI).

Authors:  Ronald C Kessler; T Bedirhan Ustün
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

5.  MRI brain volume abnormalities in young, nonpsychotic relatives of schizophrenia probands are associated with subsequent prodromal symptoms.

Authors:  Beng-Choon Ho
Journal:  Schizophr Res       Date:  2007-08-29       Impact factor: 4.939

6.  Alcoholism and timing of separation in parents: findings in a midwestern birth cohort.

Authors:  Mary Waldron; Kathleen K Bucholz; Michael T Lynskey; Pamela A F Madden; Andrew C Heath
Journal:  J Stud Alcohol Drugs       Date:  2013-03       Impact factor: 2.582

7.  A Risk Calculator to Predict the Individual Risk of Conversion From Subthreshold Bipolar Symptoms to Bipolar Disorder I or II in Youth.

Authors:  Boris Birmaher; John A Merranko; Tina R Goldstein; Mary Kay Gill; Benjamin I Goldstein; Heather Hower; Shirley Yen; Danella Hafeman; Michael Strober; Rasim S Diler; David Axelson; Neal D Ryan; Martin B Keller
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-08-07       Impact factor: 8.829

8.  Affective modulation of the startle response among children at high and low risk for anxiety disorders.

Authors:  A Kujawa; C R Glenn; G Hajcak; D N Klein
Journal:  Psychol Med       Date:  2015-04-27       Impact factor: 7.723

9.  Alcohol challenge responses predict future alcohol use disorder symptoms: a 6-year prospective study.

Authors:  Andrea C King; Patrick J McNamara; Deborah S Hasin; Dingcai Cao
Journal:  Biol Psychiatry       Date:  2013-10-02       Impact factor: 13.382

10.  A randomized controlled trial of venlafaxine XR for major depressive disorder after spinal cord injury: Methods and lessons learned.

Authors:  Charles H Bombardier; Jesse R Fann; Catherine S Wilson; Allen W Heinemann; J Scott Richards; Ann Marie Warren; Larry Brooks; Catherine A Warms; Nancy R Temkin; Denise G Tate
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.